SOUTH PASADENA, Calif., June 24, 2003 (PRIMEZONE) -- It has come to the attention of the Company that there is an erroneous Form 3 filing under Viral Genetics (OTCBB:VRAL) in the EDGAR database maintained by the Securities and Exchange Commission.
The Form 3 was filed June 5, 2003, under the name of Noel J. Guillama. The Form 3 erroneously reports that Mr. Guillama holds stock in Viral Genetics and is an officer and director of Viral Genetics.
Mr. Guillama has no such reported stock ownership and is not an officer or director. The Company has notified the SEC of the error and is in the process of having the Form 3 removed from the EDGAR database.
Viral Genetics, Inc., a development-stage Delaware Corporation, was founded in 1995 to discover, develop and commercialize therapeutic and diagnostic systems for the treatment of viral diseases.
The company website is www.viralgenetics.com. Viral Genetics, Inc. 905 Mission Street South Pasadena, CA 91030
Safe Harbor Statement under the Private Securities Reform Act of 1995: Except for the historical information herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties including, but not limited to economic, competitive, governmental and technological factors affecting the Company's operations, markets, products and prices, and other factors discussed in the Company's various filings with the Securities and Exchange Commission.
More information on this company can be found on eWorldWire's Online Newsroom at:
HTML: http://newsroom.eworldwire.com/view_release.php?id=1467
PDF: http://newsroom.eworldwire.com/pdf/view_pdf.php?id=1467
ONLINE NEWSROOM: http://newsroom.eworldwire.com/newsroom.php?cid=1471